ATCC

ATCC

The American Type Culture Collection is a nonprofit biological materials repository founded in 1925 that preserves, authenticates, and distributes reference strains and cell lines to researchers, institutions, and companies. It supports scientific reproducibility and translational research by supplying authenticated microorganisms, cell cultures, and molecular reference materials to laboratories involved with pharmaceuticals, agriculture, public health, and biotechnology. ATCC’s collections and services underpin work at universities, companies, and government agencies worldwide and intersect with institutions such as the National Institutes of Health, Centers for Disease Control and Prevention, and World Health Organization.

History

ATCC was established during an era of expanding biomedical research, with early connections to institutions like the Rockefeller Institute for Medical Research, Harvard University, and Johns Hopkins University. Throughout the 20th century its holdings grew through exchanges with organizations including the Pasteur Institute, Max Planck Institute, and the United States Department of Agriculture. During World War II and the postwar period ATCC’s role grew alongside efforts at the National Academy of Sciences, Cold Spring Harbor Laboratory, and the Carlsberg Laboratory to standardize biological materials. In subsequent decades collaborations with the National Institutes of Health, Food and Drug Administration, and pharmaceutical firms such as Eli Lilly and Company helped integrate authenticated strains into regulatory and drug development pipelines. ATCC collections expanded with inputs from global centers including the University of Tokyo, Institut Pasteur, and the Chinese Academy of Sciences. Landmark initiatives paralleled developments at institutions like the Wellcome Trust, Salk Institute, and the Howard Hughes Medical Institute, reflecting shifts in molecular biology, virology, and cell culture techniques. ATCC has interacted with international frameworks such as the Nagoya Protocol, World Health Organization programs, and standards efforts involving the International Organization for Standardization and American Society for Testing and Materials.

Collections and Services

ATCC houses bacteria, fungi, viruses, plasmids, and human and animal cell lines used across fields represented by Harvard Medical School, Stanford University School of Medicine, Massachusetts Institute of Technology, and the University of California system. Its collections support work at biotechnology companies like Genentech, Biogen, and Amgen, agricultural research at USDA laboratories and Rothamsted Research, and diagnostics development at Roche and Abbott Laboratories. Services include authentication assays employed by laboratories affiliated with the Centers for Disease Control and Prevention, genetic sequencing collaborations with Illumina and Thermo Fisher Scientific, and cryopreservation techniques shared with Cold Spring Harbor Laboratory and Scripps Research. ATCC issues reference materials utilized in regulatory submissions to the Food and Drug Administration and Health Canada, and partners with repositories such as the European Collection of Authenticated Cell Cultures, Japanese Collection of Research Bioresources, and Korean Cell Line Bank. Educational materials and training support institutions like the American Society for Microbiology, Royal Society, and New York University.

Research and Standards Contributions

ATCC contributes to standardization and reproducibility efforts alongside organizations such as the International Council for Laboratory Animal Science, National Institute of Standards and Technology, and Clinical and Laboratory Standards Institute. It has supported genomic reference projects linked to the Human Genome Project, collaborations with the Broad Institute, and microbial genomics studies at the European Molecular Biology Laboratory. ATCC provides authenticated reference strains used in method validation studies for diagnostics companies, clinical laboratories associated with Mayo Clinic and Cleveland Clinic, and environmental monitoring programs at the Environmental Protection Agency. Its role intersects with patent and intellectual property landscapes involving the United States Patent and Trademark Office and World Intellectual Property Organization, and with accreditation frameworks used by laboratories under the Joint Commission and College of American Pathologists. ATCC’s materials underpin research cited in journals published by Nature Publishing Group, Cell Press, and the Proceedings of the National Academy of Sciences.

Quality Control and Accreditation

Quality assurance at ATCC follows principles promoted by organizations including the International Organization for Standardization, American National Standards Institute, and the International Accreditation Service. Authentication procedures include molecular characterization techniques developed with partners such as the Sanger Institute, Pacific Biosciences, and Oxford Nanopore Technologies, and sterility and contamination control aligned with guidelines from the World Health Organization and Centers for Disease Control and Prevention. ATCC’s practices support compliance with regulatory requirements enforced by the Food and Drug Administration and European Medicines Agency, and facilitate accreditation for client laboratories by bodies such as the College of American Pathologists and ISO-accredited testing facilities. Training and proficiency testing programs reference standards from Clinical and Laboratory Standards Institute and engage professional societies like the American Society for Clinical Pathology and Association of Biomolecular Resource Facilities.

Partnerships and Global Impact

ATCC collaborates with universities, national laboratories, and international repositories including the Pasteur Institute, Max Planck Society, Chinese Academy of Sciences, and European Molecular Biology Laboratory to broaden access to authenticated materials. Partnerships with philanthropic organizations such as the Bill & Melinda Gates Foundation and Wellcome Trust have supported capacity building in lower- and middle-income countries and initiatives linked to global health priorities championed by the World Health Organization and Gavi, the Vaccine Alliance. Industry alliances with pharmaceutical and diagnostics companies accelerate translational projects at institutions like Pfizer, Novartis, and Johnson & Johnson, while consortia involving the National Institutes of Health, Defense Advanced Research Projects Agency, and European Commission address biodefense and public-health emergencies. ATCC’s global impact is visible in collaborative research published by teams at MIT, UC Berkeley, Imperial College London, and Karolinska Institutet, and in adoption of standardized reference materials by laboratories across continents.

Category:Biological repositories